Adaptive immune response inhibits ectopic mature bone formation induced by BMSCs/BCP/plasma composite in immune-competent mice

Tissue Engineering - Part A

Volumn 20, Issue 21-22, 2014, Pages 2950-2962

  Bouvet Gerbettaz, Sébastien ^a   Boukhechba, Florian ^a,b,c   Balaguer, Thierry ^a,b,c,d   Schmid Antomarchi, Heidy ^a,b,c   Michiels, Jean François ^a,d   Scimeca, Jean Claude ^a,b,c   Rochet, Nathalie ^a,b,c  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b CNRS   (France)

^c CENTRE DE BIOCHIMIE   (France)

^d UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM PHOSPHATE; CELL ENGINEERING; CYTOLOGY; GENE EXPRESSION; IMMUNE SYSTEM; MAMMALS; T-CELLS; TISSUE; TISSUE REGENERATION;

ADAPTIVE IMMUNE RESPONSE; BIPHASIC CALCIUM PHOSPHATES; BONE MARROW STROMAL CELLS (BMSCS); BONE TISSUE ENGINEERING; CYTOTOXIC T LYMPHOCYTES; GENE EXPRESSION PROFILES; IN-SITU HYBRIDIZATION; MULTINUCLEATED GIANT CELLS;

BONE;

BIPHASIC CALCIUM PHOSPHATE; CALCIUM PHOSPHATE; UNCLASSIFIED DRUG; CALCIUM PHOSPHATE, MONOBASIC, ANHYDROUS;

ADAPTIVE IMMUNITY; ADIPOCYTE; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW STROMA CELL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ERYTHROBLAST; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GIANT CELL; HEMATOPOIETIC CELL; HEMATOPOIETIC TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LEUKOCYTE; LEUKOCYTE COUNT; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCYTE; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; ANIMAL; BONE DEVELOPMENT; C57BL MOUSE; CELL CULTURE; IMMUNOCOMPETENCE; IMMUNOLOGY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; NUDE MOUSE; PLASMA; PROCEDURES;

ADAPTIVE IMMUNITY; ANIMALS; BONE DEVELOPMENT; CALCIUM PHOSPHATES; CELLS, CULTURED; IMMUNOCOMPETENCE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MICE, NUDE; PLASMA;

EID: 84909951053     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2013.0633     Document Type: Article

References (50)

1. Krebsbach, P.H., Kuznetsov, S.A., Satomura, K., Emmons, R.V., Rowe, D.W., and Robey, P.G. Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation 63, 1059, 1997.
2. Kuznetsov, S.A., Krebsbach, P.H., Satomura, K., Kerr, J., Riminucci, M., Benayahu, D., and Robey, P.G. Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J Bone Miner Res 12, 1335, 1997.
3. Gronthos, S., Mankani, M., Brahim, J., Robey, P.G., and Shi, S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci USA 97, 13625, 2000.
4. Cooper, L.F., Harris, C.T., Bruder, S.P., Kowalski, R., and Kadiyala, S. Incipient analysis of mesenchymal stem-cell-derived osteogenesis. J Dent Res 80, 314, 2001.
5. Shi, S., Gronthos, S., Chen, S., Reddi, A., Counter, C.M., Robey, P.G., and Wang, C.Y. Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression. Nat Biotechnol 20, 587, 2002.
6. Simonsen, J.L., Rosada, C., Serakinci, N., Justesen, J., Stenderup, K., Rattan, S.I., Jensen, T.G., and Kassem, M. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol 20, 592, 2002.
7. Kasten, P., Vogel, J., Luginbühl, R., Niemeyer, P., Tonak, M., Lorenz, H., Helbig, L., Weiss, S., Fellenberg, J., Leo, A., Simank, H.G., and Richter, W. Ectopic bone formation associated with mesenchymal stem cells in a resorbable calcium deficient hydroxyapatite carrier. Biomaterials 26, 5879, 2005.
8. Xia, Z., Taylor, P.R., Locklin, R.M., Gordon, S., Cui, Z., and Triffitt, J.T. Innate immune response to human bone marrow fibroblastic cell implantation in CB17 scid/beige mice. J Cell Biochem 98, 966, 2006.
9. Fang, D., Seo, B.M., Liu, Y., Sonoyama, W., Yamaza, T., Zhang, C., Wang, S., and Shi, S. Transplantation of mes-enchymal stem cells is an optimal approach for plastic surgery. Stem Cells 25, 1021, 2007.
10. Liu, Y., Wang, L., Kikuiri, T., Akiyama, K., Chen, C., Xu, X., Yang, R., Chen, W., Wang, S., and Shi, S. Mesenchy-mal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-g and TNF-a. Nat Med 17, 1594, 2011.
11. Tasso, R., Augello, A., Boccardo, S., Salvi, S., Caridà, M., Postiglione, F., Fais, F., Truini, M., Cancedda, R., and Pennesi, G. Recruitment of a host's osteoprogenitor cells using exogenous mesenchymal stem cells seeded on porous ceramic. Tissue Eng Part A 15, 2203, 2009.
12. Boukhechba, F., Balaguer, T., Bouvet-Gerbettaz, S., Mi-chiels, J.F., Bouler, J.M., Carle, G.F., Scimeca, J.C., and Rochet, N. Fate of bone marrow stromal cells in a syngenic model of bone formation. Tissue Eng Part A 17, 2267, 2011.
13. Balaguer, T., Boukhechba, F., Clave, A., Bouvet-Gerbettaz, S., Trojani, C., Michiels, J.F., Laugier, J.P., Bouler, J.M., Carle, G.F., Scimeca, J.C., and Rochet, N. Biphasic calcium phosphate microparticles for bone formation: benefits of combination with blood clot. Tissue Eng Part A 16, 3495, 2010.
14. Bouvet-Gerbettaz, S., Merigo, E., Rocca, J.P., Carle, G.F., and Rochet, N. Effects of low-level laser therapy on proliferation and differentiation of murine bone marrow cells into osteoblasts and osteoclasts. Lasers Surg Med 41, 291, 2009.
15. Theise, N.D., Badve, S., Saxena, R., Henegariu, O., Sell, S., Crawford, J.M., and Krause, D.S. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology 31, 235, 2000.
16. Theise, N.D., Henegariu, O., Grove, J., Jagirdar, J., Kao, P.N., Crawford, J.M., Badve, S., Saxena, R., and Krause, D.S. Radiation pneumonitis in mice: a severe injury model for pneumocyte engraftment from bone marrow. Exp He-matol 30, 1333, 2002.
17. Mankani, M.H., Kuznetsov, S.A., Fowler, B., Kingman, A., and Robey, P.G. In vivo bone formation by human bone marrow stromal cells: effect of carrier particle size and shape. Biotechnol Bioeng 72, 96, 2001.
18. Gronthos, S., Zannettino, A.C., Hay, S.J., Shi, S., Graves, S.E., Kortesidis, A., and Simmons, P.J. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 116, 1827, 2003.
19. Luttikhuizen, D.T., Harmsen, M.C., and Van Luyn, M.J. Cellular and molecular dynamics in the foreign body reaction. Tissue Eng 12, 1955, 2006.
20. Anderson, J.M., Rodriguez, A., and Chang, D.T. Foreign body reaction to biomaterials. Semin Immunol 20, 86, 2008.
21. Brodbeck, W.G., and Anderson, J.M. Giant cell formation and function. Curr Opin Hematol 16, 53, 2009.
22. Franz, S., Rammelt, S., Scharnweber, D., and Simon, J.C. Immune responses to implants-A review of the implications for the design of immunomodulatory biomaterials. Biomaterials 32, 6692, 2011.
23. Rodriguez, A., Macewan, S.R., Meyerson, H., Kirk, J.T., and Anderson, J.M. The foreign body reaction in T-cell-deficient mice. J Biomed Mater Res A 90, 106, 2009.
24. Higgins, D.M., Basaraba, R.J., Hohnbaum, A.C., Lee, E.J., Grainger, D.W., and Gonzalez-Juarrero, M. Localized im-munosuppressive environment in the foreign body response to implanted biomaterials. Am J Pathol 175, 161, 2009.
25. Rice, J.M., Hunt, J.A., and Gallagher, J.A. Quantitative evaluation of the biocompatible and osteogenic properties of a range of biphasic calcium phosphate (BCP) granules using primary cultures of human osteoblasts and mono-cytes. Calcif Tissue Int 72, 726, 2003.
26. Lange, T., Schilling, A.F., Peters, F., Haag, F., Morlock, M.M., Rueger, J.M., and Amling, M. Proinflammatory and osteoclastogenic effects of beta-tricalciumphosphate and hydroxyapatite particles on human mononuclear cells in vitro. Biomaterials 30, 5312, 2009.
27. Fellah, B.H., Delorme, B., Sohier, J., Magne, D., Hardouin, P., and Layrolle, P. Macrophage and osteoblast responses to biphasic calcium phosphate microparticles. J Biomed Mater Res A 93, 1588, 2010.
28. Lange, T., Schilling, A.F., Peters, F., Mujas, J., Wicklein, D., and Amling, M. Size dependent induction of proin-flammatory cytokines and cytotoxicity of particulate beta-tricalciumphosphate in vitro. Biomaterials 32, 4067, 2011.
29. Velard, F., Braux, J., Amedee, J., and Laquerriere, P. Inflammatory cell response to calcium phosphate biomaterial particles: an overview. Acta Biomater 9, 4956, 2013.
30. Anderson, J.M., and McNally, A.K. Biocompatibility of implants: lymphocyte/macrophage interactions. Semin Im-munopathol 33, 221, 2011.
31. Ghanaati, S., Barbeck, M., Detsch, R., Deisinger, U., Hil-big, U., Rausch, V., Sader, R., Unger, R.E., Ziegler, G., and Kirkpatrick, C.J. The chemical composition of synthetic bone substitutes influences tissue reactions in vivo: histo-logical and histomorphometrical analysis of the cellular inflammatory response to hydroxyapatite, beta-tricalcium phosphate and biphasic calcium phosphate ceramics. Biomed Mater 7, 1, 2012.
32. Wolf, M., and Moser, B. Antimicrobial activities of che-mokines: not just a side effect? Front Immunol 3, 213, 2012.
33. Schmidt-Bleek, K., Schell, H., Lienau, J., Schulz, N., Hoff, P., Pfaff, M., Schmidt, G., Martin, C., Perka, C., Buttgereit, F., Volk, H.D., and Duda, G. Initial immune reaction and angiogenesis in bone healing. J Tissue Eng Regen Med 8, 120, 2014.
34. Holmbeck, K., Bianco, P., Caterina, J., Yamada, S., Kro-mer, M., Kuznetsov, S.A., Mankani, M., Robey, P.G., Poole, A.R., Pidoux, I., Ward, J.M., and Birkedal-Hansen, H. MT1-MMP-deficient mice develop dwarfism, osteope-nia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99, 81, 1999.
35. Holmbeck, K., Bianco, P., Pidoux, I., Inoue, S., Bill-inghurst, R.C., Wu, W., Chrysovergis, K., Yamada, S., Birkedal-Hansen, H., and Poole, A.R. The metalloprotei-nase MT1-MMP is required for normal development and maintenance of osteocyte processes in bone. J Cell Sci 118, 147, 2005.
36. Kirkbride, K.C., Townsend, T.A., Bruinsma, M.W., Bar-nett, J.V., and Blobe, G.C. Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor. J Biol Chem 283, 7628, 2008.
37. Nishida, C., Kusubata, K., Tashiro, Y., Gritli, I., Sato, A., Ohki-Koizumi, M., Morita, Y., Nagano, M., Sakamoto, T., Koshikawa, N., Kuchimaru, T., Kizaka-Kondoh, S., Seiki, M., Nakauchi, H., Heissig, B., and Hattori, K. MT1-MMP plays a critical role in hematopoiesis by regulating HIF-mediated chemo-/cytokine gene transcription within niche cells. Blood 119, 5405, 2012.
38. Chun, T.H., Sabeh, F., Ota, I., Murphy, H., McDonagh, K.T., Holmbeck, K., Birkedal-Hansen, H., Allen, E.D., and Weiss, S.J. MT1-MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix. J Cell Biol 167, 757, 2004.
39. Beertsen, W., Holmbeck, K., Niehof, A., Bianco, P., Chrysovergis, K., Birkedal-Hansen, H., and Everts, V. Inhibition of molar eruption and root elongation in MT1-MMP-deficient mice. Connect Tissue Res 1, 298, 2003.
40. Holmbeck, K., Bianco, P., Yamada, S., and Birkedal-Hansen, H. MT1-MMP: a tethered collagenase. J Cell Physiol 200, 11, 2004.
41. Lu, C., Li, X.Y., Hu, Y., Rowe, R.G., and Weiss, S.J. MT1-MMP controls human mesenchymal stem cell trafficking and differentiation. Blood 115, 221, 2010.
42. Betz, U.A., Bloch, W., van den Broek, M., Yoshida, K., Taga, T., Kishimoto, T., Addicks, K., Rajewsky, K., and Müller, W. Postnatally induced inactivation of gp130 in mice results in neurological, cardiac, hematopoietic, immunological, hepatic, and pulmonary defects. J Exp Med 188, 1955, 1998.
43. Yao, L., Yokota, T., Xia, L., Kincade, P.W., and McEver, R.P. Bone marrow dysfunction in mice lacking the cytokine receptor gp130 in endothelial cells. Blood 106, 4093, 2005.
44. Sims, N.A., and Walsh, N.C. GP130 cytokines and bone remodelling in health and disease. BMB Rep 43, 513, 2010.
45. Christenbury, J.D. Absence of quantitative effects of het-erozygosity of the nude gene on lymphocyte populations in the mouse. Proc Okla Acad Sci 57, 12, 1977.
46. Anghelina, M., Krishnan, P., Moldovan, L., and Moldovan, N.I. Monocytes/macrophages cooperate with progenitor cells during neovascularization and tissue repair: conversion of cell columns into fibrovascular bundles. Am J Pa-thol 168, 529, 2006.
47. Nauta, A.J., and Fibbe, W.E. Immunomodulatory properties of mesenchymal stromal cells. Blood 110, 3499, 2007.
48. Dayan, V., Yannarelli, G., Billia, F., Filomeno, P., Wang, X.H., Davies, J.E., and Keating, A. Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/macrophages after acute myocardial infarction. Basic Res Cardiol 106, 1299, 2011.
49. Toben, D., Schroeder, I., El Khassawna, T., Mehta, M., Hoffmann, J.E., Frisch, J.T., Schell, H., Lienau, J., Serra, A., Radbruch, A., and Duda, G.N. Fracture healing is accelerated in the absence of the adaptive immune system. J Bone Miner Res 26, 113, 2011.
50. Schmidt-Bleek, K., Schell, H., Schulz, N., Hoff, P., Perka, C., Buttgereit, F., Volk, H.D., Lienau, J., and Duda, G.N. Inflammatory phase of bone healing initiates the regenerative healing cascade. Cell Tissue Res 347, 567, 2012.